Insights into the clinical and molecular epidemiology of an infections outbreak of human parvovirus B19 in France, 2023–2024
The recent epidemic of B19V infections re-illustrates the immunity gap of the post-pandemic COVID-19 pandemic. This highlight the impact of any outbreak on at-risk population and the need for a more global and genomic surveillance.
Authors
- Céline Lambert (ORCID: https://orcid.org/0000-0002-6459-4800)
- Christel Regagnon
- Christine Archimbaud (ORCID: https://orcid.org/0000-0001-7665-5618)
- Jean‐Luc Bailly (ORCID: https://orcid.org/0000-0002-9770-6450)
- Matthieu Picard (ORCID: https://orcid.org/0000-0003-3108-5804)
- Maxime Bisseux (ORCID: https://orcid.org/0000-0002-3489-049X)
- Elisa Creuzet (ORCID: https://orcid.org/0000-0002-1045-5688)
- Hélène Chabrolles (ORCID: https://orcid.org/0000-0001-8038-2130)
- Amélie Brebion (ORCID: https://orcid.org/0000-0003-4829-8224)
- Ophélie Perruche
- Cécile Henquell (ORCID: https://orcid.org/0000-0003-2859-6566)
- Audrey Mirand (ORCID: https://orcid.org/0000-0002-9638-2415)
- Wendy Pulby
- Siméon Bakyono
Institutions
- Centre National de la Recherche Scientifique (FR)
- Nutreov Laboratoires (France) (FR)
- Laboratoire Microorganismes Génome et Environnement (FR)
- Clermont Université (FR)
Publication Details
- Journal
- Journal of Clinical Virology
- Published
- 2025-04-18
- DOI
- https://doi.org/10.1016/j.jcv.2025.105798
- Citations
- 6
- Primary Topic
- Parvovirus B19 Infection Studies
- Type
- article
- Field-Weighted Citation Impact
- 8.38